Menu

Some Human Cancers Exhibit Low-grade Inflammation

NSAIDs reduce this "parainflammation," hinting at how they help lower cancer risk.

Oct 1, 2016
Alison F. Takemura

SIMMER DOWN: A mouse adenoma organoid treated with an NSAID (right) has less parainflammation (orange marker; control on the left). HEBREW UNIVERSITY OF JERUSALEM, AUDREY LASRY AND GENOME BIOL, 17:145, 2016

EDITOR'S CHOICE IN CELL & MOLECULAR BIOLOGY

The paper
D. Aran et al., “Widespread parainflammation in human cancer,” Genome Biol, 17:145, 2016.

Smoldering threat
Researchers in Israel were trying to understand why a particular mouse model was so unusually cancer-prone once it suffered a mutation in the tumor suppressor gene p53. They noticed that the animal’s epithelial tissue showed signs of low-grade inflammation, undetectable by normal hallmarks such as white blood cell recruitment. Intriguingly, treating the mutated mouse with a nonsteroidal anti-inflammatory drug (NSAID) reduced its risk of cancer—an effect observed in some human studies as well.

Smoke signals
To explore what was driving this so-called parainflammation (PI), the team recently collaborated with Dvir Aran of the University of California, San Francisco, and colleagues to identify its genetic signature, and found an upregulation of 40 genes. The researchers then analyzed gene expression data from more than 800 human cancer cell lines and from about 6,500 patient tumor samples, including 18 cancer types, to uncover whether any harbored this signature.

Striking a match
By scoring gene expression data based on their similarity to the PI signature, the team found four cancers—including lung and pancreatic adenocarcinomas—with notably higher tallies. Mutations in p53 were also associated with a higher PI score. The prognoses for these cancers were dramatically worse, suggesting PI might exacerbate cancer progression.

Cooling cancer
When the team treated mouse adenoma organoids and two human cancer cell lines with an NSAID, the expression of PI genes fell by more than half. The findings could translate to the clinic, by helping to identify patients who would benefit from NSAID treatment, says Michael Karin, who studies inflammation in colorectal cancer at UC San Diego. “Right now, nobody is stratifying the patients,” he says.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!